← Back to Search

Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD (CALM Trial)

N/A
Waitlist Available
Led By Naomi Simon, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks, 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing CALM Breathing, a special breathing exercise program for adults with COPD and anxiety sensitivity. The program uses devices to monitor and give feedback on breathing patterns, helping patients learn to control their breathing. The goal is to reduce symptoms like shortness of breath and stress, and improve quality of life.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks, 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CALM Breathing Satisfaction Rating
Drop-Out Rate
Mean Attendance Rate of CALM Breathing Treatment Sessions
Secondary study objectives
6 Mile Walking Distance Score (6MWT)
Change in COPD Assessment Test (CAT) Score
Chronic Respiratory Disease Questionnaire (CRQ) Score
+8 more
Other study objectives
Self-Evaluation of Breathing Questionnaire (SEBQ) Score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CALM BreathingExperimental Treatment1 Intervention
Group II: Wait-List ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CALM Breathing
2021
N/A
~50

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,413 Previous Clinical Trials
855,708 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,492 Previous Clinical Trials
2,664,816 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
862 Previous Clinical Trials
674,059 Total Patients Enrolled
Naomi Simon, MDPrincipal InvestigatorNYU Langone
4 Previous Clinical Trials
231 Total Patients Enrolled
Anna Norweg, PhD, OTRPrincipal InvestigatorColumbia University
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top